Doorgaan naar hoofdcontent

Human medicines European public assessment report (EPAR): Optruma, raloxifene, Osteoporosis, Postmenopausal, Date of ...

 

 
 
Human medicines European public assessment report (EPAR): Optruma, raloxifene, Osteoporosis, Postmenopausal, Date of authorisation: 05/08/1998, Revision: 24, Status: Authorised
Human medicines European public assessment report (EPAR): Optruma, raloxifene, Osteoporosis, Postmenopausal, Date of authorisation: 05/08/1998, Revision: 24, Status: Authorised



 
 
EMA and ECDC update on COVID-19, , 14/07/2021
Complete vaccination courses vital for maximum protectionVaccination remains one of the best protective measures against COVID-19. Recommendations for...



 
 
CareDx AB, FSN-A-2021-091, Olerup QTYPE 11
Urgent Field Safety Notice Olerup QTYPE 11 E047.


Actueel zorgnieuws in jouw mailbox ontvangen?
Direct het hele artikel lezen? Meld je aan voor de nieuwsbrief.